Home/Werewolf Therapeutics/Timothy P. Reilly, Ph.D.
TP

Timothy P. Reilly, Ph.D.

Chief Operating Officer

Werewolf Therapeutics

Roles

Chief Operating OfficeratWerewolf Therapeutics
Chief Development OfficeratHOOKIPA Pharma

Therapeutic Areas

Werewolf Therapeutics Pipeline

DrugIndicationPhase
WTX-124Advanced or metastatic solid tumorsPhase 1
WTX-330Advanced or metastatic solid tumors / non-Hodgkin lymphomaPhase 1
WTX-518UndisclosedPreclinical
WTX-712UndisclosedPreclinical